232 related articles for article (PubMed ID: 11522838)
21. Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo.
Sohail M; Hochegger H; Klotzbücher A; Guellec RL; Hunt T; Southern EM
Nucleic Acids Res; 2001 May; 29(10):2041-51. PubMed ID: 11353073
[TBL] [Abstract][Full Text] [Related]
22. Thermodynamic and kinetic characterization of antisense oligodeoxynucleotide binding to a structured mRNA.
Walton SP; Stephanopoulos GN; Yarmush ML; Roth CM
Biophys J; 2002 Jan; 82(1 Pt 1):366-77. PubMed ID: 11751323
[TBL] [Abstract][Full Text] [Related]
23. How RNase HI (Escherichia coli) promoted site-selective hydrolysis works on RNA in duplex with carba-LNA and LNA substituted antisense strands in an antisense strategy context?
Plashkevych O; Li Q; Chattopadhyaya J
Mol Biosyst; 2017 May; 13(5):921-938. PubMed ID: 28352859
[TBL] [Abstract][Full Text] [Related]
24. Hybridization of antisense reagents to RNA.
Sohail M; Southern EM
Curr Opin Mol Ther; 2000 Jun; 2(3):264-71. PubMed ID: 11249620
[TBL] [Abstract][Full Text] [Related]
25. Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development.
Orum H; Wengel J
Curr Opin Mol Ther; 2001 Jun; 3(3):239-43. PubMed ID: 11497347
[TBL] [Abstract][Full Text] [Related]
26. Antisense phosphorothioate oligonucleotides direct both site-specific and nonspecific RNAse H cleavage of in vitro synthesized p120 mRNA.
Weidner DA; Busch H
Oncol Res; 1994; 6(6):237-42. PubMed ID: 7865899
[TBL] [Abstract][Full Text] [Related]
27. Properties of nicked and circular dumbbell RNA/DNA chimeric oligonucleotides containing antisense phosphodiester oligodeoxynucleotides.
Yamakawa H; Abe T; Saito T; Takai K; Yamamoto N; Takaku H
Bioorg Med Chem; 1998 Jul; 6(7):1025-32. PubMed ID: 9730239
[TBL] [Abstract][Full Text] [Related]
28. Mixed backbone antisense oligonucleotides: design, biochemical and biological properties of oligonucleotides containing 2'-5'-ribo- and 3'-5'-deoxyribonucleotide segments.
Kandimalla ER; Manning A; Zhao Q; Shaw DR; Byrn RA; Sasisekharan V; Agrawal S
Nucleic Acids Res; 1997 Jan; 25(2):370-8. PubMed ID: 9016567
[TBL] [Abstract][Full Text] [Related]
29. RNase H is responsible for the non-specific inhibition of in vitro translation by 2'-O-alkyl chimeric oligonucleotides: high affinity or selectivity, a dilemma to design antisense oligomers.
Larrouy B; Boiziau C; Sproat B; Toulmé JJ
Nucleic Acids Res; 1995 Sep; 23(17):3434-40. PubMed ID: 7567453
[TBL] [Abstract][Full Text] [Related]
30. mRNA accessible site tagging (MAST): a novel high throughput method for selecting effective antisense oligonucleotides.
Zhang HY; Mao J; Zhou D; Xu Y; Thonberg H; Liang Z; Wahlestedt C
Nucleic Acids Res; 2003 Jul; 31(14):e72. PubMed ID: 12853649
[TBL] [Abstract][Full Text] [Related]
31. Potent and selective inhibition of gene expression by an antisense heptanucleotide.
Wagner RW; Matteucci MD; Grant D; Huang T; Froehler BC
Nat Biotechnol; 1996 Jul; 14(7):840-4. PubMed ID: 9631007
[TBL] [Abstract][Full Text] [Related]
32. Selection of optimal antisense accessible sites of uroplakin II mRNA for bladder urothelium.
Zheng L; Tong Q; Chen F; Zeng F; Wang L; Dong J
J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):344-9. PubMed ID: 19513619
[TBL] [Abstract][Full Text] [Related]
33. Suppression of c-jun by antisense oligonucleotides inhibits cell adhesion but not respiratory burst during phorbol ester-induced differentiation of U937 human monoblastic cells.
Momiyama N; Shimada H; Mitsuhashi M
Cell Growth Differ; 1996 Aug; 7(8):1005-12. PubMed ID: 8853896
[TBL] [Abstract][Full Text] [Related]
34. Determination of potent antisense oligonucleotides in vitro by semiempirical rules.
Yanagihara N; Tadakuma H; Ishihama Y; Okabe K; Funatsu T
J Biosci Bioeng; 2007 Mar; 103(3):270-7. PubMed ID: 17434431
[TBL] [Abstract][Full Text] [Related]
35. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
Kronenwett R; Haas R; Sczakiel G
J Mol Biol; 1996 Jun; 259(4):632-44. PubMed ID: 8683570
[TBL] [Abstract][Full Text] [Related]
36. RNA accessibility prediction: a theoretical approach is consistent with experimental studies in cell extracts.
Scherr M; Rossi JJ; Sczakiel G; Patzel V
Nucleic Acids Res; 2000 Jul; 28(13):2455-61. PubMed ID: 10871393
[TBL] [Abstract][Full Text] [Related]
37. Stable transfection of U937 cells with sense or antisense RXR-alpha cDNA suggests a role for RXR-alpha in the control of monoblastic differentiation induced by retinoic acid and vitamin D.
Brown TR; Stonehouse TJ; Branch JS; Brickell PM; Katz DR
Exp Cell Res; 1997 Oct; 236(1):94-102. PubMed ID: 9344589
[TBL] [Abstract][Full Text] [Related]
38. Programmed cell death by hok/sok of plasmid R1: processing at the hok mRNA 3'-end triggers structural rearrangements that allow translation and antisense RNA binding.
Franch T; Gultyaev AP; Gerdes K
J Mol Biol; 1997 Oct; 273(1):38-51. PubMed ID: 9367744
[TBL] [Abstract][Full Text] [Related]
39. RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus.
Liang XH; Sun H; Nichols JG; Crooke ST
Mol Ther; 2017 Sep; 25(9):2075-2092. PubMed ID: 28663102
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibition of cell-free translation by oligonucleotides targeted to a mRNA hairpin structure.
Le Tinévez R; Mishra RK; Toulmé JJ
Nucleic Acids Res; 1998 May; 26(10):2273-8. PubMed ID: 9580674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]